Publications, webinars, and presentations

Peer Reviewed Publications (selected)

Lasky T, “In the Real-World, Kids Use Medications and Devices” Drugs – Real-World Outcomes, 2017

Lasky T, “Arsenic in Chicken: A Tale of Data and Policy” Journal of Epidemiology and Community Health, 2017

Lasky T, Artaman A, Czaja A, Maruti S, Osokogu O, Verhamme KMC, Sobel R “Current Needs in Pediatric Pharmacoepidemiology”, Pharmacoepidemiology and Drug Safety, January 2016

Lasky T, Greenspan J, Ernst FR, Gonzalez L, “Pediatric Vancomycin Use in 421 Hospitals in the United States, 2008”, PLoS ONE 7(8): e43258, 2012

Lasky T,Ernst FR, Greenspan J, “Use of analgesic, anesthetic and sedative medications in pediatric hospitalizations in the US 2008”, Anesthesia and Analgesia 115:1155-61, 2012

Lasky T, Ernst FR, Greenspan J, Gonzalez L, “Morphine Use in Hospitalized Children in the United States: A Descriptive Analysis of Data From Pediatric Hospitalizations in 2008”, Clinical Therapeutics 2012

Lasky T, Greenspan J, Ernst FR, Gonzalez L, “Dopamine and Dobutamine Use in Preterm or Low Birth Weight Neonates in the Premier 2008 Database”, Clinical Therapeutics 33(12):2082-2088, 2011

Lasky T, Kogut S, Campbell S, Risica PM, “Computer Kiosks to Deliver Medication Information in the Pharmacy”, Journal of Consumer Health on the Internet 15(4):1-13, 2011

Lasky T, Krieger A, Elixhauser A, Vitiello B: “Children’s Hospitalizations with a Mood Disorder Diagnosis in General Hospitals in the United States 2000-2006”, Child and Adolescent Psychiatry and Mental Health 5:27, 2011

Lasky T, “’Observation Days’ in a Kafkaesque Hospital Setting”, International Journal of User-Driven Healthcare 1(2), 66-69, 2011

Lasky T, Ernst FR, Greenspan J, Wang S, Gonzalez L “Estimating pediatric inpatient medication use in the United States”, Pharmacoepidemiology and Drug Safety 19:1-7, 2011

Lasky T, Lawless S, Greenspan J “Quality Care for Children: Inpatient Pediatric Medication Use in a mid-Atlantic hospital system 2000-2003”, American Journal of Medical Quality 25(3):225-231, 2010

Lasky T, “Estimates of Pediatric Medication Use in United States: Current Abilities and Limitations”, Clinical Therapeutics 31(2);436-445, 2009

Ward RM, Benitz WE, Benjamin DK, Blackmon L, Giacoia G, Hudak M, Lasky T, Rodriguez W, Selen A “Criteria Supporting the Study of Drugs in the Newborn”, Clinical Therapeutics 28(9);1385-1398, 2006

Koehler K, Lasky T, Fein S, et al. “Population-based incidence of Infection With Selected Bacterial Enteric Pathogens in Children Less than Five Years of Age, 1996-1998”, Pediatric Infectious Disease Journal 25(2):129-134, 2006

Lasky T, Sun W, Kadry A, Hoffman M “Mean Total Arsenic Concentrations in Chicken 1989-2000 and Estimated Exposures for Consumers of Chicken”, Environmental Health Perspectives 112:18-21, 2004

Lasky T “Foodborne Illness – Old Problem, New Relevance”, Epidemiology 13(5):593-598, 2002

Centers for Disease Control and Prevention, DHHS “Preliminary FoodNet Data on the Incidence of Foodborne Illnesses: Selected Sites, United States, 2001”, Morbidity and Mortality Weekly Report. April 19, 2002

MacMillan C, Magder LS, Brouwers P, Chase C, Hittelman J, Lasky T, Malee K, Mellins CA, Velez-Borras J “Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women”, Neurology 23;57(8):1402-11, 2001

Smith R, Malee K, Charurat M, Magder L, Mellins C, Macmillan C, Hittleman J, Lasky T, Llorente A, Moye J for the NIH NIAID/NICHD/NIDA sponsored Women and Infant Transmission Study Group “Timing of Perinatal HIV-1 Infection and Rate of Neurodevelopment”, Pediatric Infectious Disease Journal 19(9):862-71, 2000

Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley P, Schonberger LB, Chen RT “Guillain-Barré Syndrome and the Influenza Vaccines of 1992-93 and 1993-94”, The New England Journal of Medicine 339(25):1797-1802, 1998

Lasky T and Magder L “Hepatocellular Carcinoma p53 G>T Transversions at Codon 249: The “Fingerprint” of Aflatoxin Exposure?”, Environmental Health Perspectives 105(4):392-397, 1997

Lasky T and Silbergeld E “p53 Mutations Associated with Breast, Colon, Liver, Lung, and Ovarian Cancers”, Environmental Health Perspectives 104(12):1324-1331, 1996

Lasky T, Stolley PD “Selection of Cases and Controls”, Epidemiologic Reviews 16(1):17-22, 1994


Lasky T What Pharmacists Need to Know About Racial and Ethnic Health Disparities, MIE Resources, Rhode Island, 2013

Lasky T Epidemiologic Principles and Food Safety, Oxford University Press, New York, 2007

Stolley PD, Lasky T Investigating Disease Patterns: The Science of Epidemiology, Scientific American Library, W.H. Freeman,1995

Presentations (selected)

Lasky T “Systematic Literature Review and Meta-Analysis in Pharmacoepidemiology” 29th International Conference on Pharmacoepidemiology, Montreal, Canada 2013

Lasky T “Issues in Pediatric Comparative Effectiveness Research” Anderson Center for Health Systems Excellence, Cincinnati Children’s Hospital 2011

Lasky T, Greenspan J, Ernst FR, Gonzalez L. “Prevalence of Morphine Use in Pediatric Inpatients in the US, 2008,” 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL 2011

Lasky T, Greenspan J, Ernst FR, Wang S, Gonzalez L “Vancomycin use in Children Hospitalized in the United States in 2008” presented at the 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Brighton, England 2010

Lasky T, Krieger A, Elixhauser A, Vitiello B “Children’s hospitalizations for affective and mood disorders in the US 2000-2006”, Annual Meeting American Academy of Child & Adolescent Psychiatry 2009

Reynolds, M and Lasky T “Meta-analysis for Drug Development and Risk Management” 25th International Conference for Pharmacoepidemiology and Therapeutic Risk Management, Rhode Island 2009

Lasky T, “Prioritization of Drugs for Study under the Best Pharmaceuticals for Children Act”, Center for Outcomes Effectiveness, AHRQ, Gaithersburg, MD, 2007

Elixhauser A, Lasky T, Baskin R, “HCUP: A National Information Resource to Support Children’s Health Care Research and to inform Health Care Policy and Practice” Annual Meeting Academy Health, Boston 2005

Lasky T, “BPCA: The Annual Drug Prioritization Process” presented at the 40th Annual Meeting of the Drug Information Association, Washington, DC, 2004

Lasky T, The Guillain-Barre Syndrome and the 1992-3 and 1993-94 Influenza Vaccines, invited presenter, Institute of Medicine, Immunization Safety Review Committee, 2003

Lasky T, Magder L, Koski CL, Stolley P, Ballesteros M, Nash D, Chen R, Haber P, Schonberger L, Terriacciano Investigation of a Possible Association Between Guillain-Barre Syndrome and the 1992-93 and 1993-94 Influenza Vaccinations. Advisory Committee on Immunization Practices, Centers for Disease Control 1997

Lasky T Investigation of a Possible Association Between Guillain-Barre Syndrome and the 1992-93 and 1993-94 Influenza Vaccinations. Division of Biostatistics and Epidemiology, Food and Drug Administration, Rockville, Maryland 1997

Lasky T, Magder L, Koski CL, Stolley P, Ballesteros M, Nash D, Chen R, Haber P, Schonberger L, Terriacciano Association of Guillain-Barre Syndrome with 1992-93 and 1993-94 Influenza Vaccines. National Immunization Program 1997